SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Patients with chronic kidney disease (CKD) and heart failure have higher rates of inpatient dialysis initiation than those without heart failure.

Patients who undergo surgery immediately preceding the weekend have an increased risk for complications, readmission, and mortality at 30 days, 90 days, and one year compared with those undergoing ...

Comorbid lung function impairment was associated with increased risks for cardiovascular disease and mortality in type 2 diabetes.

Breast cancer survivors who receive chemotherapy may experience greater physical health decline than those who receive endocrine therapy alone.

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Researchers found variation in continuous glucose monitoring (CGM), with glycemic index for a commercial fruit smoothie higher with CGM vs capillary sampling.

The executive order most directly affecting gender-affirming care is the one that directly attempts to shut down ...